Effect of ARNi (Angiotensin Receptor–Neprilysin Inhibitors) in Post Mitral Valve Replacement / Repair patients with Heart Failure: A Retrospective Analysis
Background: Arrhythmias Induced Cardiomyopathy (AiCM) is generally a reversible condition triggered by Tachycardia, Atrial fibrillation (AF) or Premature Ventricular Contractions (PVC). The most important pillar in the Management of the AiCM remains the initiation of therapy for control of Arrhythmias (Medical management or Ablations) with the optimization of HF management
Methods: We had Seven patient of mitral valve disease who underwent open heart surgery. Post-surgery they developed signs and symptoms of heart failure along with arrhythmias (AF) and deteriorating Ejection Fraction (EF)Results: When even after optimal drug therapy their symptoms were not controlled, they were switched to ARNi from ACEi. On 6 months of therapy their symptoms improved along with their EF, QOL and arrhythmias Conclusions: So, we concluded that in these subset of patients ARNi can be tried to manage AiCM with good clinical results.
2. Rakesh Gopinathannair, Susan P. Etheridge, Francis E. Marchlinski, Francis G. Spinale, DhanunjayaLakkireddy, Brian Olshansky,Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management, Journal of the American College of Cardiology,Volume 66, Issue 15,2015,Pages 1714-1728,ISSN 0735-1097.
3. McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. doi:10.1056/NEJMoa1409077.
4. Januzzi JL Jr, Camacho A, Piña IL, et al. Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. Circ Heart Fail. 2020;13(6):e006946. doi:10.1161/CIRCHEARTFAILURE.119.006946.
Copyright (c) 2020 Amit Srivastava, Sanjay Kumar, Mohd Azam Haseen, Arvind Kumar Pandey
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.